High expression of HLA-E by tumor cells, TAM and dendritic cells can dampen the anti-tumor immune response of tumor-infiltrating CD8 T cells and NK cells, activating the inhibitory axis NKG2A/HLA-E (57). The gene discussed is KLRC1; the disease is neoplasm.